Join Growin Stock Community!

恒大1325.TW Overview

TW StockPlastics
(No presentation for 1325)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

恒大（1325）Overall Performance

恒大（1325）AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

恒大（1325） PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

恒大（1325）Key Information

恒大（1325）Profile

Universal Incorporation manufactures and sells nonwoven fabrics and medical face masks in Taiwan. The company offers SMMS and SMS fabrics for use in the hygiene, medical, and industrial markets; spun bond fabrics that are used in the hygiene, medical, industrial, and agricultural markets; and melt blown fabrics for use in filtration, insulators, and absorbents. It also provides medical face masks, which are used to prevent spit infections, bacteria, and dusts. In addition, the company offers treatment products for in-line and post treatments, as well as outsourcing services, such as non-woven and film laminations, ultrasonic bonding, coatings, and printings. Universal Incorporation was founded in 1962 and is based in Taipei City, Taiwan.

恒大（1325）FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-1.12
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
8.12
PB Ratio
0.92
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
-15.30%
Net Margin
-31.80%
Revenue Growth (YoY)
-16.70%
Profit Growth (YoY)
-160.55%
3-Year Revenue Growth
-25.66%
3-Year Profit Growth
-2.36%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-1.12
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
8.12
PB Ratio
0.92
Price-to-FCF
-
Gross Margin
-15.30%
Net Margin
-31.80%
Revenue Growth (YoY)
-16.70%
Profit Growth (YoY)
-160.55%
3-Year Revenue Growth
-25.66%
3-Year Profit Growth
-2.36%
default symbol

1325

恒大

28.60D

-1.75%

(-0.02)

  • When is 1325's latest earnings report released?

    The most recent financial report for 恒大 (1325) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 1325's short-term business performance and financial health. For the latest updates on 1325's earnings releases, visit this page regularly.

  • What is the operating profit of 1325?

    According to the latest financial report, 恒大 (1325) reported an Operating Profit of -28.84M with an Operating Margin of -46.64% this period, representing a decline of 17.58% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is 1325's revenue growth?

    In the latest financial report, 恒大 (1325) announced revenue of 61.83M, with a Year-Over-Year growth rate of -13.47%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much cash does 1325 have?

    At the end of the period, 恒大 (1325) held Total Cash and Cash Equivalents of 388.17M, accounting for 0.14 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does 1325 go with three margins increasing?

    In the latest report, 恒大 (1325) did not achieve the “three margins increasing” benchmark, with a gross margin of -28.91%%, operating margin of -46.64%%, and net margin of -6.95%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 1325's profit trajectory and future growth potential.

  • Is 1325's EPS continuing to grow?

    According to the past four quarterly reports, 恒大 (1325)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at -0.05. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of 1325?

    恒大 (1325)'s Free Cash Flow (FCF) for the period is -12.64M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 351.89% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.